SCHEMBL8552832

SCHEMBL8552832

CCCN1CCC(c2coc3ccc(NC(=O)NCCCc4ccccc4)cc23)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.52
SLC6A4 P31645 1/20 0.52
HTR2A P28223 10/20 0.47
DRD3 P35462 9/20 0.47
CCR3 P51677 3/20 0.46
CCR2 P41597 1/20 0.45
MCHR1 Q99705 1/20 0.45
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
CNR1 P21554 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RAB9A P51151 1/20 0.45
CXCR3 P49682 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551485 0.89 DRD2 (0.52) DRD2SLC6A4HTR2ADRD3CCR2
SCHEMBL8703395 0.87 DRD2 (0.61) DRD2SLC6A4HTR2ADRD3
SCHEMBL8707882 0.83 DRD2 (0.54) DRD2SLC6A4HTR2ADRD3
SCHEMBL7480617 0.83 CCR2 (0.61) DRD2CCR2
SCHEMBL8551299 0.83 DRD2 (0.52) DRD2SLC6A4HTR2ACCR3CCR2
SCHEMBL8547948 0.83 DRD2 (0.56) DRD2SLC6A4HTR2ADRD3
SCHEMBL8550257 0.83 DRD2 (0.54) DRD2SLC6A4HTR2ADRD3
SCHEMBL8703719 0.83 DRD2 (0.53) DRD2SLC6A4HTR2ADRD3
SCHEMBL8547950 0.80 DRD2 (0.57) DRD2SLC6A4HTR2ADRD3
SCHEMBL8551604 0.80 UBE2M (0.49) DRD2SLC6A4HTR2ADRD3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5792763-A MIGRAINES; ANALGESICS; DISEASES LINKED TO DECREASED NEUROTRANMISSION OF SEROTONIN IN MAMMALS ELI LILLY AND COMPANY (US) 1998-08-11 US disclosed
EP-0835869-A2 New serotonin 5-HT1F agonists ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed